Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy

Journal of the American Society of Nephrology

Volumn 18, Issue 12, 2007, Pages 3139-3146

  Giannakakis, Konstantinos ^a   Feriozzi, Sandro ^b   Perez, Marie ^c   Faraggiana, Tullio ^a   Muda, Andrea Onetti ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BELCOLLE HOSPITAL   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLYCOSYLATION; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MALE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

EID: 36849086542     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007030259     Document Type: Article

References (35)

1. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64: 709-727, 1987
2. Conley ME, Cooper MD, Michael AF: Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 66: 1432-1436, 1980
3. Barratt J, Feehally J: IgA nephropathy. J Am Soc Nephrol 16: 2088-2097, 2005
4. Donadio JV, Grande JP: IgA nephropathy. N Engl J Med 347: 738-748, 2002
5. Allen AC, Feehally J: IgA1 glycosylation and the pathogenesis of IgA nephropathy. Am J Kidney Dis 35: 551-556, 2000
6. Coppo R, Amore A: Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65: 1544-1547, 2004
7. Feehally J, Allen AC: Structural features of IgA molecules which contribute to IgA nephropathy. J Nephrol 12: 59-65, 1999
8. Tomana M, Novac J, Julian B, Matousovic K, Konecny K, Mestecky J: Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104: 73-81, 1999
9. Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M: Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int 62: 465-475, 2002
10. Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J: IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67: 504-513, 2005
11. Kokubo T, Hiki Y, Iwase H, Tanaka A, Toma K, Hotta K, Kobayashi Y: Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 9: 2048-2054, 1998
12. Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K: Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59: 1077-1085, 2001
13. Allen AC, Bailey EM, Brenchley PE, Buck KS, Barratt J, Feehally J: Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients. Kidney Int 60: 969-973, 2001
14. Oortwijn BD, Van Der Boog PJ, Roos A, Van der Geest RN, De Fijter JW, Daha MR, Van Kooten C: A pathogenic role for secretory IgA in IgA nephropathy. Kidney Int 69: 1131-1138, 2006
15. Stockert RJ, Kressner MS, Collins JC, Sternlieb I, Morell AG: IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci U S A 79: 6229-6231, 1982
16. Amore A, Cirina P, Conti G, Brusa P, Peruzzi L, Coppo R: Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 12: 1862-1871, 2001
17. Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C: Differential glycosylation of polymeric and monomeric IgA: A possible role in glomerular inflammation in IgA nephropathy. J Am Soc Nephrol 17: 3529-3539, 2006
18. Welch TR: The complement system in renal diseases. Nephron 88: 199-204, 2001
19. Janssen U, Bahlmann F, Kohl J, Zwirner J, Haubitz M, Floege J: Activation of the acute phase response and complement C3 in patients with IgA nephropathy. Am J Kidney Dis 35: 21-28, 2000
20. Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M, Fujita T: Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant 13: 1984-1990, 1998
21. Roos A, Bouwman LH, Van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha M: Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 167: 2861-2868, 2001
22. Haas M: Histology and immunohistology of IgA nephropathy. J Nephrol 18: 676-680, 2005
23. Onetti Muda A, Feriozzi S, Rahimi S, Faraggiana T: Spatial arrangement of IgA and C3 as a prognostic indicator of IgA nephropathy. J Pathol 177: 201-208, 1995
24. Xu L-X, Yan Y, Zhang J-J, Zhang Y, Zhao M-H: The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy. Clin Exp Immunol 142: 569-575, 2005
25. Xu L-X, Zhao M-H: Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int 68: 167-172, 2005
26. Barratt J, Feehally J, Smith AC: Pathogenesis of IgA nephropathy. Semin Nephrol 24: 197-217, 2004
27. Amore A, Coppo R: Modulation of mesangial cells reactivity by aberrantly glycosylated IgA. Nephron 86: 255-259, 2000
28. Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, Van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha M: Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17: 1724-1734, 2006
29. Peruzzi L, Amore A, Cirina P, Trusolino L, Basso G, Ricotti E, Emancipator SN, Marchisio PC, Coppo R: Integrin expression and IgA nephropathy: In vitro modulation by IgA with altered glycosylation and macromolecular IgA. Kidney Int 58: 2331-2340, 2000
30. Amore A, Conti G, Cirina P, Peruzzi L, Alpa M, Bussolino F, Coppo R: Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells. Am J Kidney Dis 36: 1242-1252, 2000
31. Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC: Engagement of transferrin receptor by polymeric IgA1: Evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol 16: 2667-2676, 2005
32. Haas M: Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis 29: 829-842, 1997
33. Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS: Histological grading of IgA nephropathy predicting renal outcome: Revisiting H. S. Lee's glomerular grading system. Nephrol Dial Transplant 20: 342-348, 2005
34. Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE: Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data. Kidney Int 45: 544-550, 1994
35. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65: 521-530, 2004